NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









52North

52North

Private
CambridgeHealthcare & Life Scienceshttps://52north.health/

Last Round

Grant

Dec 3, 2024

Total Funding Raised

$10.22M

Company Overview

52North is a medical technology company that develops in-vitro diagnostic and digital solutions to transform patient journeys in urgent care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Defense Tech, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticsportable diagnostic deviceremote patient monitoringPOC testingdigital healthmedtechclinical decision supportat-home diagnosticsdefense technologydual-use technologyremote triagebiomarker measurementhealth IoTtelemedicineAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

52North Comparables

Compare 52North with similar companies based on industry and business-model similarity.

52North comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Entia
91%
Commure
73%
Soulbrain Holdings Co. Ltd
69%

52North Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 3, 2024
SeedDec 3, 2024
GrantNov 22, 2022
SeedApr 29, 2022

Key People

Founding team and executive leadership

Umaima Malik Ahmad

CEO & Co-Founder, Co-Founder

Founding Team

Joe Neale

Chief Technology Officer

Executive Team

Rebecca Simmons

Chief Operating Officer

Executive Team

52North Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2024

    $1.5M grant from the National Institute for Health and Care Research.

52North Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

52North Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 52North's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range26
Year Founded2018
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.